Other News To Note
Tuesday, May 31, 2011
Archer Pharmaceuticals Inc., of Sarasota, Fla., said an international research consortium led by researchers at Trinity College Dublin said they were recommended for funding for a large-scale European Phase III trial of Nilvadipine in Alzheimer's disease. The grant is awarded by the European Commission Seventh Framework Programme.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.